The director of the Centers for Disease Control and Prevention (CDC) warned on Wednesday that the recent decline in cases of coronavirus, hospitalizations and deaths showed signs of stagnation.
“We knew it would happen as variants emerged and reached more people in more communities, but we could still reduce its impact,” Walensky said.
The US is currently seeing an average of seven days of 66,010 new cases of coronavirus, which was an increase of 3.5% compared to the previous week, while deaths also increased by 2.2% from the previous week.
KROGER TO Pursue MASKS ON OUR SUPERMARKETS Despite TEXAS, MISSISSIPPI LEVY MANDATE
“Today we are in a critical connection in the pandemic, so much can turn around in the next few weeks,” Walensky said. “On the one hand, the cases in the country are declining at rates just on the basis of the possibility of resuscitation, and the B.1.1.7 transferable variant is ready to slash our success so far. And on the other hand, endurance has become thin, fatigue is gaining ground and the exact measures we have taken to stop the pandemic are now too often flagrally ignored. ‘
Walensky’s warning comes when several states repeal coronavirus restrictions such as mask mandates and restrictions on indoor gatherings. Texas, for example, on Tuesday got rid of its mask mandate which is the largest state to do so.
OREGON CONFIRMS BRAZIL CORONAVIRUS SEVERAL CASE, FIRST ON WEST COAST
The Biden government, which on Tuesday announced that the U.S. will have enough vaccine to vaccinate every adult by May, has repeatedly urged the public to continue using masks regardless of the state’s mandate. Walensky again called on people to ‘reach out’ and continue to follow public health measures in order to ‘protect the country’s health and our loved ones’.
“How it plays out depends on us, the next three months are crucial,” she said.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
As far as variants are concerned, dr. Anthony Fauci said that the National Institutes of Health is working with vaccine manufacturers to investigate different approaches to promoting the effectiveness of the vaccine. He has previously outlined several approaches, including creating new boosters to target the variant, such as those developed by Moderna against the South African strain, or simply boosting the existing vaccine to boost the antibody titer against the wild-type virus. increase.